The thyroid drug Neo-Mercazole (carbimazole) is currently available in Australia only through the Special Access Scheme (SAS) until mid-November due to a global shortage of the drug.
A new alert released by the TGA on Friday, confirmed that many pharmacies had run out of Neo-Mercazole, however supplies could be obtained by a pharmacist by contacting Link Healthcare after either approval from the TGA after SAS Category has been obtained or by providing a completed SAS Category A notification form.
From mid-November, Link Healthcare will be supplying to pharmacies a different carbimazole product, Carbimazole ARISTO 5mg. When it becomes available the need to use the SAS process will stop.
No comments:
Post a Comment